Zimmer Biomet Holdings (ZBH) Non-Current Deferred Tax Liability (2011 - 2026)
Zimmer Biomet Holdings (ZBH) posted Non-Current Deferred Tax Liability of $235.6 million for Q2 2026, down 5.72% on a QoQ basis from $249.9 million in Q1 2026.
Analysis
Zimmer Biomet Holdings (ZBH) Non-Current Deferred Tax Liability (2011 - 2026) Analysis & Trends
Zimmer Biomet Holdings has reported Non-Current Deferred Tax Liability for 15 years, with the latest figure at $235.6 million in Q2 2026.
- On a quarterly basis, Non-Current Deferred Tax Liability changed N/A year-over-year to $235.6 million in Q2 2026; TTM through Jun 2026 was $235.6 million, a N/A change from a year earlier, with the FY2025 full-year figure at $244.1 million, down 30.75% from the prior year.
- Non-Current Deferred Tax Liability was $235.6 million for Q2 2026 at Zimmer Biomet Holdings, down from $249.9 million in the prior quarter.
- The five-year high for Non-Current Deferred Tax Liability was $541.3 million in Q3 2022, with the low at $235.6 million in Q2 2026.
- Average Non-Current Deferred Tax Liability over 5 years is $405.2 million, with a median of $465.4 million recorded in 2023.
- The sharpest annual moves came in 2022 and 2023: Non-Current Deferred Tax Liability slumped 35.99% in 2022, then decreased 1.12% in 2023.
- Over 5 years, Non-Current Deferred Tax Liability stood at $474.8 million in 2022, then decreased by 24.68% to $357.6 million in 2023, then declined by 1.43% to $352.5 million in 2024, then sank by 30.75% to $244.1 million in 2025, then retreated by 3.48% to $235.6 million in 2026.
- The last three Non-Current Deferred Tax Liability figures came in at $235.6 million (Q2 2026), $249.9 million (Q1 2026), and $244.1 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn |
| 9 | Steris | 21.90 Bn | 21.43 Bn | 684.20 Mn |
| 10 | Zimmer Biomet Holdings | 18.70 Bn | 18.30 Bn | 1.54 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 235.60 Mn |
| Mar 31, 2026 | 249.90 Mn |
| Dec 31, 2025 | 244.10 Mn |
| Dec 31, 2024 | 352.50 Mn |
| Mar 31, 2024 | 370.40 Mn |
| Dec 31, 2023 | 357.60 Mn |
| Sep 30, 2023 | 465.40 Mn |
| Jun 30, 2023 | 474.90 Mn |
| Mar 31, 2023 | 484.60 Mn |
| Dec 31, 2022 | 474.80 Mn |
| Sep 30, 2022 | 541.30 Mn |
| Jun 30, 2022 | 526.20 Mn |
| Mar 31, 2022 | 490.10 Mn |
| Dec 31, 2021 | 558.50 Mn |
| Sep 30, 2021 | 693.90 Mn |
| Jun 30, 2021 | 722.80 Mn |
| Mar 31, 2021 | 765.70 Mn |
| Dec 31, 2020 | 790.40 Mn |
| Sep 30, 2020 | 747.80 Mn |
| Jun 30, 2020 | 804.90 Mn |